Mark Lewis Selected Research

Mark Lewis Research Topics

Disease

7	Infections 01/2016 - 08/2006
4	Neoplasms (Cancer) 01/2024 - 10/2022
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 08/2006
2	Ileus 05/2024 - 08/2021
2	Adenoma (Adenomas) 01/2024 - 04/2023
2	Flatulence 10/2018 - 08/2002
2	Pain (Aches) 10/2018 - 08/2007
2	Mastitis 01/2018 - 08/2017
2	Spondylolisthesis 12/2009 - 04/2009
1	Intervertebral Disc Degeneration 04/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2023
1	Autistic Disorder (Autism) 08/2023
1	Myotonic Dystrophy (Dystrophia Myotonica) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 02/2022
1	Mutism (Selective Mutism) 09/2020
1	Epilepsy (Aura) 09/2020
1	Autism Spectrum Disorder 09/2020
1	Acute Cholecystitis 01/2020
1	Rubella (German Measles) 01/2020
1	Ulcerative Colitis 12/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Postoperative Pain 10/2018
1	Cholangiocarcinoma 12/2017
1	Hyperaldosteronism (Conn Syndrome) 11/2017
1	Hypertension (High Blood Pressure) 11/2017
1	Tendinopathy (Tendonitis) 01/2017
1	Radius Fractures (Radius Fracture) 03/2016
1	Inflammation (Inflammations) 01/2016
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2014
1	Obesity 10/2012
1	Breast Neoplasms (Breast Cancer) 09/2012
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2012
1	Vascular Malformations 04/2012
1	Disease Progression 02/2011

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2020 - 08/2008
4	AntibodiesIBA 01/2020 - 02/2011
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 05/2024 - 08/2021
2	SalicylatesIBA 01/2024 - 04/2023
2	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2024 - 04/2023
2	DNA VaccinesIBA 01/2020 - 05/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 08/2007
2	Antiviral Agents (Antivirals)IBA 01/2016 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2014
1	SteroidsIBA 04/2024
1	CytokinesIBA 01/2024
1	Single-Domain AntibodiesIBA 01/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2024
1	Radioisotopes (Radionuclides)IBA 11/2023
1	Everolimus FDA Link 11/2023
1	Sunitinib (Sutent)FDA Link 11/2023
1	Peptide Receptors (Peptide Receptor)IBA 11/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2023
1	RNA (Ribonucleic Acid)IBA 08/2023
1	RNA Splicing FactorsIBA 08/2023
1	PerhexilineIBA 02/2022
1	Medical MarijuanaIBA 09/2020
1	CannabidiolIBA 09/2020
1	CannabinoidsIBA 09/2020
1	Rubella VaccineIBA 01/2020
1	AutoantigensIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Ropivacaine (Naropin)FDA LinkGeneric 10/2018
1	Opioid Analgesics (Opioids)IBA 10/2018
1	Local AnestheticsIBA 10/2018
1	Analgesics (Analgesic Drugs)IBA 10/2018
1	Ketamine FDA LinkGeneric 10/2018
1	Genetic Markers (Genetic Marker)IBA 01/2018
1	EnzymesIBA 11/2017
1	3 beta-hydroxysteroid dehydrogenase type IIIBA 11/2017
1	SaltsIBA 11/2017
1	CryptochromesIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2017
1	tabunIBA 03/2015
1	Broadly Neutralizing AntibodiesIBA 01/2015
1	TetraspaninsIBA 01/2014
1	Combined VaccinesIBA 01/2014
1	Small Heat-Shock ProteinsIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Neutralizing AntibodiesIBA 01/2013
1	gadofosveset trisodium (MS 325)FDA Link 04/2012
1	Contrast MediaIBA 04/2012

Therapy/Procedure

8	Therapeutics 11/2023 - 08/2006
3	Injections 04/2024 - 08/2007
3	Drug Therapy (Chemotherapy) 11/2023 - 09/2012
2	Length of Stay 05/2024 - 08/2002
2	Colectomy 12/2019 - 10/2018
2	Pedicle Screws 12/2009 - 04/2009
1	Oral Administration 04/2023
1	Pelvic Exenteration 10/2022
1	Laparoscopic Cholecystectomy 01/2020
1	Immunotherapy 01/2020
1	Art Therapy 01/2020
1	Enhanced Recovery After Surgery 10/2018
1	Polypharmacy 10/2018
1	Conservative Treatment 01/2017
1	Surgical Casts (Plaster Cast) 03/2016
1	Mass Drug Administration 01/2014
1	Punctures 10/2012
1	Sclerotherapy 04/2012